Tobacco-Associated Lesions of the Oral Cavity: Part I. Nonmalignant Lesions

(Lésions de la cavité buccale associées au tabac. Partie I. Lésions bénignes)

Sayed M. Mirbod, DDS, M.Sc. •
Stephen I. Ahing, DDS, FRCD(C) •


La consommation excessive de produits du tabac a été associée à divers types de lésions de la cavité buccale, par exemple : formation de taches sur les dents, abrasions, mélanose du fumeur, gingivite ulcéronécrosante aiguë et autres parodontopathies, brûlures et plaques kératosiques, langue noire pileuse, stomatite due à la nicotine, érosions du palais, leucoplasie, dysplasie épithéliale et épithélioma spinocellulaire. L’examen intra-buccal de routine par un professionnel de la santé dentaire peut toutefois permettre de révéler la plupart de ces lésions à un stade précoce et favoriser ainsi une intervention hâtive qui pourra éviter de graves séquelles. Le dépistage des lésions associées au tabac, combiné à des conseils sur l’usage du tabac dispensés par les professionnels dentaires, est devenu la norme en matière de soins. Cette première partie d’une série de deux articles traite de la signification et du traitement des lésions bénignes associées au tabac. Les lésions malignes, ainsi que les principes fondamentaux de la biopsie et les stratégies de prévention et d’intervention, sont examinés dans la deuxième partie.

Mots clés MeSH : mouth mucosa/pathology; smoking/adverse effects; tobacco, smokeless/adverse effects

© J Can Dent Assoc 2000; 66:252-6
Cet article a fait l’objet d’une révision par des pairs.

Tobacco was first introduced in Europe by Spanish and Portuguese explorers of America in the early 16th century.1 The different ways in which tobacco is used lead to considerable variation in appearance, site and frequency of the lesions associated with the tobacco habit. In Western countries, cigarettes, cigars and pipes are the major ways in which tobacco is used, but chewing tobacco and snuff dipping (smokeless tobacco) have become more popular in recent years.1

Despite the attention given to tobacco as a major etiologic factor in leukoplakia, epithelial dysplasia and squamous-cell carcinoma, several other tobacco-associated lesions are known. Although malignant and nonmalignant lesions associated with tobacco use are discussed separately in this article, tobacco use could result in the presence of more than one type of lesion in any individual patient. The major nonmalignant oral lesions associated with the tobacco habit are described under dental, gingival and mucosal conditions.

Dental Conditions

A dark brown to black discolouration of the cervical margins of teeth caused by tar and other by-products of combustion is commonly associated with smoking.2 Other concomitant causes of extrinsic staining, such as dietary substances (e.g., coffee or tea), may contribute to the discolouration (Fig. 1). The history of a tobacco habit helps in determining the correct diagnosis and etiology. Although deposits are primarily of esthetic concern, they may also promote plaque accumulation.3 Treatment consists of mechanical polishing with mild abrasives. However, the stains will quickly reappear with continued tobacco use. Specially formulated toothpastes or home use tooth-whitening systems can be useful adjuncts in the removal or masking of tobacco stains.4

Pipe smoking and the use of smokeless tobacco are commonly associated with tooth abrasion.5,6 Abrasion from pipe smoking occurs on the occlusal surfaces in association with placement of the pipe stem, whereas abrasion from smokeless tobacco usually occurs on the vestibular surface opposite the wad of smokeless tobacco, but may involve the occlusal surfaces if the tobacco is chewed (Fig. 2). Abrasion may result in dentin hypersensitivity, pulp exposure or apertognathia (open bite). Apertognathia develops in pipe smokers and usually occurs unilaterally on the smoker’s favourite side. Individualized treatment may include dentin desensitization, endodontics and crowns.

Gingival Conditions

Acute necrotizing ulcerative gingivitis (ANUG) is a painful and rapidly progressive disease of the free gingiva, attached gingiva and alveolar mucosa characterized by necrosis of the gingival papilla accompanied by halitosis (Fig. 3). ANUG primarily affects young adults who smoke heavily and have poor oral hygiene.3 Although the exact interaction between ANUG and smoking is not clear, local and systemic effects have been suggested.7 The progression of ANUG may be enhanced by plaque accumulation in sites with tar deposits and tissue ischemia secondary to nicotinic vasoconstriction.8 Without treatment, ANUG may occasionally progress to involve the marginal alveolar bone.

Initial therapy for cases uncomplicated by bone involvement includes debridement under local anesthetic, instruction in oral hygiene and increasing awareness of the role of tobacco. Dramatic resolution of gingival lesions is often seen within 48 to 72 hours with these measures alone. Antibiotics, when indicated, should be considered as adjunctive to local debridement. Penicillin and metronidazole are both effective in cases of severe ANUG or where debilitation is known or suspected.7 Frequent follow-up is necessary until the interdental papillary contour returns to normal. If this does not occur, periodontal surgical intervention may be necessary.9

Although gingivitis and periodontitis are caused by bacteria, smoking has been strongly implicated as a risk factor for the initiation and propagation of periodontal diseases (Table 1)10 Smoking has been associated with increased calculus deposition, which can accelerate plaque accumulation, recession and deepening of periodontal pockets.11 The prevalence of periodontitis is greater in smokers than nonsmokers12 and the alveolar bone is more susceptible to resorption in smokers.13 Several biologic mechanisms have been suggested. Smoking has been implicated in impairing normal host immunity in terms of neutralizing infection,14 in adverse effects on neutrophil function15 and in reducing gingival blood flow.16 Cigarette smoking has been associated with impaired healing and less improvement in pocket reduction following simple pocket-reduction surgery.17

Smoker’s melanosis occurs in 25 to 31% of tobacco users and is characterized by discrete or coalescing multiple brown macules that usually involve the attached mandibular gingiva on the labial side, although pigmentation of the palate and buccal mucosa has also been associated with pipe smoking (Fig. 4).18 Smoking-associated melanosis is due to increased melanin production by melanocytes and its deposition within the basal cell layer and lamina propria. The microscopic appearance of melanosis is essentially similar to that seen in physiologic pigmentation or a melanotic macule.19 Other entities to consider in differential diagnosis are racial melanosis, melanosis due to medications, Peutz-Jegher’s syndrome, Addison’s disease and early melanoma. Smoker’s melanosis is benign and not considered to be precancerous, but a biopsy may be indicated to rule out more serious conditions, in particular melanoma. A gradual return to normal pigmentation over several months to years has been reported following smoking cessation.20

Mucosal Conditions

Burns and keratotic patches are common on the lips at the site of habitual cigarette smoking, particularly where the cigarette or cigar is retained as a stub for lengthy periods. The lesions characteristically appear on the mucosal surface of the lower and upper lips at the site at which the cigarette is held. They are characterized by flat or slightly elevated whitish areas with red striations. Cessation of smoking is the required treatment.

Lesions induced by smokeless tobacco characteristically have a wrinkled surface that ranges from opaque white to translucent and are located in the area where the snuff is held (Fig. 5). Such lesions usually resolve within a week of cessation of tobacco use. A thorough history is important in establishing the correct diagnosis; however, a biopsy may be required to rule out carcinoma or precancerous changes, especially if the lesion is associated with induration, ulceration, erythema and nonresolution within 2 weeks of stopping tobacco use.21

Hypertrophy of filiform papillae and retardation of the normal rate of desquamation on the dorsal surface of the tongue produce a hair-like appearance.22 A black hairy tongue is mainly seen in people who are heavy smokers. Clinically, the hairy tongue usually begins near the foramen cecum and spreads anteriorly and laterally with elongated filiform papillae reaching several millimeters in length. Individuals are usually asymptomatic, but may have a gagging or tickling sensation if the papillae become particularly long. A biopsy is usually not necessary for diagnosis due to the typical presentation. Scraping or brushing of the tongue and smoking cessation enhance the resolution of this problem. Trimming of the papillae may be required in extreme cases.

Nicotinic stomatitis occurs almost exclusively in heavy pipe smokers and rarely in cigarette or cigar smokers. It characteristically occurs posterior to the rugae as redness on the palate, which later assumes a grayish-white and nodular appearance due to periductal keratinization of the minor salivary glands (Fig. 6). A characteristic finding is the appearance of multiple red dots, which represent the dilated and inflamed duct openings of the minor salivary glands. Thermal and chemical agents acting locally are responsible for the occurrence of this condition. Nicotinic stomatitis is not considered to be a precancerous lesion. The treatment of choice is smoking cessation.21

Painful palatal erosions due to heavy smoking may occur in addition to nicotinic stomatitis. The erosions are due to the elevated temperature in the oral cavity for a long period. Thickening of the epithelium and white lesions may also occur. Cessation of smoking and a biopsy must be performed to rule out epithelial dysplasia or carcinoma.21

The relationship between smoking and leukoplakia is not always clear. Leukoplakia of the oral mucosa can occur in patients who have never smoked. Although cessation of tobacco use can sometimes result in resolution of tobacco-associated leukoplakic lesions, persistence of these lesions is not uncommon and this may reflect malignant transformation. A large number of oral carcinomas are associated with precursor lesions of leukoplakia; 3 to 6% of leukoplakias undergo malignant transformation, with this frequency increasing with longer follow-up periods.23,24 The presence or absence of malignant change in a lesion of oral mucosal leukoplakia cannot be reliably determined by visual examination. Limitations are also associated with commercially available toluidine blue screening kits, such as high false-negative staining rates for carcinoma in situ, moderate to severe epithelial dysplasia or both.25,26 Thus, screening for oral cancer by toluidine blue methods is not recommended. Lesions suspected of being malignant or premalignant should be investigated by prompt incisional biopsy regardless of staining reaction to toluidine blue. However, toluidine blue may be of some use in selection of the biopsy site when the patient has multifocal lesions or when a lesion is larger than 3 cm. The treatment of choice for leukoplakia is the cessation of any tobacco habit. In cases of leukoplakia associated with smokeless tobacco, the lesion almost always disappears when the use of snuff or chewing tobacco stops.

Leukoplakia in a patient with a tobacco habit should always be biopsied to determine the presence of epithelial dysplasia or a carcinoma. Epithelial dysplasia is a neoplastic transformation of epithelium without invasion into the connective tissue. The severity of epithelial dysplasia is determined by the degree and extent of architectural and cytologic changes within the epithelium; categories are mild, moderate or severe. Epithelial dysplasia may appear clinically white or red, due to hyperkeratosis or epithelial atrophy, respectively. Epithelial dysplasia that involves the full thickness of epithelium but does not invade the connective tissue is termed carcinoma in situ.

Patients with mild or moderate dysplasia have a significant, but not absolute, potential for reversibility and can be managed with the elimination of the suspected etiologic factors. Patients with severe dysplasia or carcinoma in situ have a low potential for reversibility and should be managed by complete surgical excision of the lesion(s) using a regular scalpel followed by histologic examination of the excised tissue. Surgical ablative techniques such as electrosurgery, cryosurgery and laser surgery may be employed; however, with these methods no tissue is obtained for postsurgical histologic margin assessment. This disadvantage can be partly overcome by carrying out an immediate preablative biopsy of the margins but this approach does not solve the problem of detecting microscopic foci of early invasive carcinoma that can be easily found by postsurgical microscopic examination of the entire excised lesion. Postoperative management includes long-term follow-up with regular monitoring for signs of malignant transformation and programs for cessation of tobacco use and alcohol abuse.The major mucosal lesions associated with tobacco use and their significance are summarized in Table 2.

Les auteurs n’ont aucun intérêt financier déclaré.

Écrire au : Dr Sayad M. Mirbod, Faculté de médicine dentaire, Université du Manitoba, 790, ave. Bannatyne, Winnipeg, MB R3E 0W2.

Courriel : 


1. Routh HB, Bhowmik KR, Parish JL, Parish LC. Historical aspects of tobacco use and smoking. Clin Dermatol 1998; 16:539-44.

2. Regezi J, Sciubba J. Oral pathology. Clinical-pathologic correlations. 2nd ed. Philadelphia: Saunders; 1998. p. 146-50.

3. Rateitschak KM, Rateitschak EM. Color atlas of dental medicine. Periodontology. 2nd ed. New York: Thieme Medical; 1989. p. 49-53.

4. Rosenstiel SF, Gegauff AG, Johnson WM. Randomized clinical trial of the efficacy and safety of a home bleaching procedure. Quintessence Int 1996; 27:413-24.

5. Bowles WH, Wilkinson MR, Wagner MJ, Woody RD. Abrasive particles in tobacco products: a possible factor in dental attrition. J Am Dent Assoc 1995; 126:327-31.

6. Robertson PB, Walsh MM, Greene JC. Oral effects of smokeless tobacco use by professional baseball players. Adv Dent Res 1997; 11:307-12.

7. Wade DN, Kerns DG. Acute necrotizing ulcerative gingivitis- periodontitis: a literature review. Mil Med 1998; 163:337-42.

8. Kardachi BJ, Clarke NG. Aetiology of acute necrotizing ulcerative gingivitis: a hypothetical explanation. J Periodontol 1974; 45:830-2.

9. Consensus Report. Proceedings of the world workshop in clinical periodontics: acute necrotizing ulcerative gingivitis. The American Academy of Periodontology 1989; 1:X-34.

10. Salvi GE, Lawrence HP, Offenbacher S, Beck JD. Influence of risk factors on the pathogenesis of periodontitis. Periodontology 2000 1997; 14:173-201.

11. Solomon HA, Priore R, Bross I. Cigarette smoking and periodontal disease. J Am Dent Assoc 1968; 77:1081-4.

12. Haber J, Kent RL. Cigarette smoking in a periodontal practice. J Periodontol 1992; 63:100-6.

13. Bergstrom J, Eliasson S. Cigarette smoking and alveolar bone height in subjects with a high standard of oral hygiene. J Clin Periodontol 1987; 14:466-9.

14. Seymour GJ. Importance of the host response in the periodontium. J Periodontol 1991; 18:421-6.

15. Bennet K, Reade PC. Salivary immunoglobulin A levels in normal subjects, tobacco smokers, and patients with minor aphthous ulceration. Oral Surg Oral Med Oral Pathol 1982; 53:461-5.

16. Clarke NG, Shephard BC, Hirsch RS. The effects of intra-arterial epinephrine and nicotine on gingival circulation. Oral Surg Oral Med Oral Pathol 1981; 52:577-82.

17. Preber H, Bergstrom J. Effect of cigarette smoking on periodontal healing following surgical therapy. J Clin Periodontol 1990; 17:324-8.

18. Hedin CA. Smokers’ melanosis: occurrence and localization in the attached gingiva. Arch Dermatol 1977; 113:1533-8.

19. Brown FH, Houston GD. Smoker’s melanosis: a case report. J Periodontol 1991; 62:524-7.

20. Hedin CA, Pindborg JJ, Axell T. Disappearance of smoker’s melanosis after reducing smoking. J Oral Pathol Med 1993; 22:228-30.

21. Laskaris G. Color atlas of oral diseases. 2nd ed. Stuttgart: Thieme Medical; 1994. p. 64-7.

22. Manabe M, Lim HW, Winzer M, Loomis CA. Architectural organization of filiform papillae in normal and black hairy tongue epithelium: dissection of differentiation pathways in a complex human epithelium according to their patterns of keratin expression. Arch Dermatol 1999; 135:177-81.

23. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984; 53:563-8.

24. Silverman S Jr. Oral cancer. 4th ed. Hamilton: B.C. Decker; 1998. p. 25-33.

25. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:444-6.

26. Allen CM. Toluidine blue: proceed with caution? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86:255.

Remerciements :Les auteurs tiennent à exprimer leur profonde reconnaissance aux Drs Shirley Gelskey et David Singer pour leur aide dans la révision du manuscrit.

Le Dr Mirbodest résident de deuxième année en parodontie, à l’Université du Manitoba.

Le Dr Ahingest spécialiste en pathologie buccale et chef de la section de diagnostic buccal, à l’Université du Manitoba.

Les auteurs n’ont aucun intérêt financier déclaré.

Écrire au : Dr Sayad M. Mirbod, Faculté de médicine dentaire, Université du Manitoba, 790, ave. Bannatyne, Winnipeg, MB R3E 0W2.

Courriel :